Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring
This case underscores the role of therapeutic drug monitoring in optimizing CIP dosing for patients with CF and highlights the necessity for close collaboration between clinicians and pharmacologists to ensure effective antibiotic exposure.
Authors
- Alexandra Masson‐Rouchaud
- Yeleen Fromage (ORCID: https://orcid.org/0009-0002-3356-557X)
- Jean‐Baptiste Woillard (ORCID: https://orcid.org/0000-0003-1695-0695)
- Caroline Monchaud (ORCID: https://orcid.org/0000-0002-9637-5813)
- Marc Labriffe (ORCID: https://orcid.org/0000-0001-5840-8904)
- Jeanne Languepin (ORCID: https://orcid.org/0000-0002-4646-018X)
- Hamza Sayadi
Institutions
- Inserm (FR)
- Hôpital Dupuytren (FR)
Publication Details
- Journal
- Therapeutic Drug Monitoring
- Published
- 2024-11-12
- DOI
- https://doi.org/10.1097/ftd.0000000000001267
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.45